Bacterial Amylase

Bacterial Amylase Market Outlook

The global Bacterial Amylase market is projected to reach approximately USD 3.5 billion by 2035, expanding at a remarkable CAGR of around 8.5% from 2025 to 2035. This growth is primarily driven by the increasing demand for enzymes in various industries, such as food and beverage, pharmaceuticals, and biofuels. Additionally, the rising trend of biotechnological advancements and the growing focus on sustainable production methods are expected to contribute significantly to market expansion. Furthermore, the shift towards healthier and organic products has prompted manufacturers to seek efficient solutions for processing, thereby enhancing the market's growth trajectory. The increasing consumer awareness about enzyme-based products and their benefits is also a crucial factor propelling the demand for bacterial amylases globally.

Growth Factor of the Market

The Bacterial Amylase market is witnessing substantial growth, influenced by several key factors. One significant driver is the rising demand for enzymes in the food and beverage sector, where bacterial amylases play a crucial role in improving quality and processing efficiency. This demand is further bolstered by the growing trend of clean label products, where consumers prefer transparency regarding ingredients. Additionally, the expansion of the textile industry, which utilizes bacterial amylase for fabric processing and treatment, contributes to increased market demand. Another aspect is the pharmaceutical industry's reliance on enzymes for drug formulation and efficacy, further augmenting market growth. Moreover, advancements in biotechnology and enzyme engineering are paving the way for the development of more efficient and targeted enzyme solutions, which is likely to enhance market potential.

Key Highlights of the Market

• Robust growth in demand from the food and beverage industry.
• Technological advancements leading to more efficient enzyme production.
• Rising consumer awareness regarding health benefits of enzyme-based products.
• Increasing applications of bacterial amylases in various industries such as textiles and pharmaceuticals.
• Growing trend towards sustainable and eco-friendly production processes.

By Product Type

Thermophilic Bacterial Amylase:

Thermophilic bacterial amylase is widely recognized for its ability to function at elevated temperatures, making it particularly useful in industrial processes that require high thermal stability. This type of amylase is commonly sourced from thermophilic bacteria such as Bacillus stearothermophilus and is extensively used in the food and beverage industry, particularly in starch liquefaction processes. Its properties not only enhance the efficiency of starch conversion but also contribute to improved flavor profiles and texture in food products. The increasing adoption of this enzyme in the production of biofuels, where high temperatures are prevalent, further supports its growth in the market, driving demand from industries focusing on sustainable energy solutions.

Mesophilic Bacterial Amylase:

Mesophilic bacterial amylase operates optimally at moderate temperatures, making it ideal for various applications across multiple industries. This enzyme type is predominantly obtained from mesophilic bacteria such as Bacillus subtilis and is extensively used in food processing, particularly in bakery products and beverages. The versatility of mesophilic amylase contributes to its popularity as it aids in the breakdown of starch into sugars, enhancing fermentation processes. Moreover, its application extends into the textile industry for desizing processes, which further bolsters its market presence. As consumer demand for cleaner and more efficient processing techniques increases, the mesophilic bacterial amylase market is poised for significant growth.

Alkaliphilic Bacterial Amylase:

Alkaliphilic bacterial amylase has gained prominence due to its ability to function efficiently in alkaline conditions, making it particularly suitable for specific industrial applications. Sourced from alkaliphilic bacteria such as Bacillus alcalophilus, this type of amylase is utilized in various sectors, including detergent production, where its stability in alkaline environments is essential. Furthermore, its application extends to the food industry, particularly in products requiring a neutral pH during processing. The growing demand for eco-friendly and biodegradable products in the detergent sector significantly contributes to the market growth of alkaliphilic bacterial amylase. As industries continue to prioritize sustainability, the relevance of this enzyme is expected to increase.

Acidophilic Bacterial Amylase:

Acidophilic bacterial amylase is characterized by its functionality in acidic conditions, making it suitable for various niche applications. This type of amylase is typically derived from acidophilic bacteria and is specifically utilized in processes where pH levels are low. Its main applications lie within the food and beverage sector, particularly in products that require acidification for enhanced flavor or preservation. Moreover, the increasing trend towards fermentation-based food products, including yogurt and vinegar, has amplified the demand for acidophilic bacterial amylase. As fermentation processes become more prevalent, this enzyme's role in improving efficiency and product quality will continue to grow in significance.

Psychrophilic Bacterial Amylase:

Psychrophilic bacterial amylase is unique for its operability at low temperatures, catering specifically to cold environments. This type of amylase is sourced from psychrophilic bacteria and is particularly valuable in applications where temperature control is critical. The food industry, especially in the production of frozen or refrigerated products, benefits from the use of psychrophilic amylase, as it helps in effectively breaking down starch without compromising the cold chain. As consumers increasingly seek convenience in cold food products, the demand for psychrophilic bacterial amylase is expected to rise, further diversifying the applications of bacterial amylases in the market.

By Application

Food & Beverage:

The food and beverage industry represents a significant segment of the Bacterial Amylase market, where these enzymes are employed to enhance various processes. Bacterial amylase aids in the breakdown of starches into sugars, which is crucial for fermentation processes in products such as beer, bread, and syrups. The increasing consumer demand for high-quality food products, coupled with the shift towards natural and enzyme-based solutions, has led to heightened utilization of bacterial amylases in food production. Moreover, the growing trend of clean-label products and the emphasis on sustainable ingredients further stimulate the demand for these enzymes, positioning the food and beverage application as a crucial contributor to market growth.

Textile:

The textile industry is another key application area for bacterial amylases, where these enzymes play a vital role in fabric processing. Bacterial amylase is primarily used for the desizing of woven fabrics, facilitating the removal of starch-based sizing agents that are applied during the weaving process. This enzymatic treatment not only improves the quality and feel of the fabric but also enhances dye uptake, leading to improved coloration and overall product appearance. As sustainability becomes increasingly important in textile manufacturing, the adoption of eco-friendly enzyme solutions such as bacterial amylases is projected to grow, driving further market expansion in this segment.

Pharmaceutical:

In the pharmaceutical sector, bacterial amylases are recognized for their significant role in various applications. These enzymes are utilized in the formulation of drugs, where they aid in the breakdown of complex carbohydrates to enhance bioavailability and absorption. The increasing focus on developing more effective and efficient pharmaceutical products drives the demand for bacterial amylases, as they contribute to improved drug formulation processes. Furthermore, the rise of biopharmaceuticals and personalized medicine fosters the need for enzyme-based solutions, positioning the pharmaceutical application as a promising growth area in the bacterial amylase market.

Paper & Pulp:

The paper and pulp industry utilizes bacterial amylases for several applications, particularly in the process of paper manufacturing and treatment. Bacterial amylases are employed to enhance fiber processing, improving the quality and yield of paper products. The enzymatic treatment helps break down starches used in coatings and finishes, leading to increased efficiency and lower production costs. As the demand for sustainable and eco-friendly paper products rises, the adoption of bacterial amylases in this industry is expected to grow. The increasing emphasis on reducing environmental impact and enhancing production efficiency will further support market expansion within the paper and pulp application.

Biofuel:

The biofuel sector has emerged as a significant application for bacterial amylases, where these enzymes are utilized in the conversion of biomass into fermentable sugars. Bacterial amylases facilitate the breakdown of starches present in various feedstocks, enhancing the efficiency of biofuel production processes. As the global demand for renewable energy sources increases, the need for efficient biofuel production methods becomes critical. Bacterial amylases contribute to the development of sustainable biofuel solutions, positioning this application as a vital growth area in the market. As countries strive to reduce their reliance on fossil fuels, the synergy between bacterial amylases and biofuel production is likely to grow stronger.

By Distribution Channel

Direct Sales:

Direct sales channels play a crucial role in the Bacterial Amylase market, as they enable manufacturers to establish direct relationships with their customers. This approach allows for better understanding and responsiveness to customer needs, ultimately improving customer satisfaction. Direct sales are particularly beneficial for industries such as food and beverage and pharmaceuticals, where specific requirements and applications are paramount. Manufacturers can provide tailored solutions and support through this channel, leading to higher sales volumes and brand loyalty. As competition intensifies, companies are likely to leverage direct sales strategies to enhance market presence and customer engagement.

Indirect Sales:

Indirect sales channels are equally important in the Bacterial Amylase market, as they broaden the reach of manufacturers and facilitate access to diverse customer segments. Through distributors and retailers, companies can penetrate various markets, including smaller businesses that may not have direct access to suppliers. This distribution model allows for efficient inventory management and logistical support, benefiting both manufacturers and end-users. Indirect sales channels are particularly valuable in regions where the food and beverage industry is rapidly growing, providing opportunities for companies to establish a foothold and expand their market share effectively. The synergy between direct and indirect sales channels is likely to drive overall market growth.

By Ingredient Type

Bacillus subtilis:

Bacillus subtilis is one of the most widely used bacterial strains in the production of amylases due to its robust enzymatic activity and safety profile. This strain is predominantly utilized in the food industry for various applications, including baking and brewing, where it enhances the fermentation process. The ability of Bacillus subtilis to produce high levels of amylase makes it a preferred choice for manufacturers aiming to improve product quality and yield. Its versatility in application, coupled with its GRAS (Generally Recognized As Safe) status, further supports its popularity and growth in the bacterial amylase market, particularly in applications requiring stringent safety standards.

Bacillus licheniformis:

Bacillus licheniformis is another significant strain used in producing bacterial amylase, known for its high enzymatic efficiency and stability under varying conditions. This strain is commonly utilized in the food and beverage industry, particularly for starch liquefaction and saccharification processes. The use of Bacillus licheniformis in industrial applications is driven by its ability to produce enzymes that function effectively at higher temperatures, making it suitable for processes requiring thermal stability. As industries continue to seek cost-effective and efficient production methods, the demand for Bacillus licheniformis-derived amylases is likely to grow, contributing to the overall market expansion.

Bacillus amyloliquefaciens:

Bacillus amyloliquefaciens is recognized for its remarkable ability to produce high levels of amylase, making it a valuable ingredient in various applications. This strain is particularly favored in the food industry for its efficiency in starch degradation, enhancing the fermentation process in brewing and baking. Additionally, its application extends to the agricultural sector, where it is utilized as a biofertilizer and biopesticide, promoting sustainable farming practices. The dual functionality of Bacillus amyloliquefaciens as both a food ingredient and an agricultural enhancer underscores its significance in the bacterial amylase market, establishing its foothold across multiple industries.

Bacillus stearothermophilus:

Bacillus stearothermophilus is a thermophilic bacterial strain that is primarily known for its high-temperature stability, making it essential for industrial applications requiring heat. This strain is commonly used in the production of biofuels, where its amylase enzyme efficiently breaks down starch at elevated temperatures, facilitating the conversion into fermentable sugars. The increasing emphasis on renewable energy sources and sustainable production methods enhances the relevance of Bacillus stearothermophilus in the market. As industries continue to prioritize resource efficiency and environmental sustainability, the demand for high-temperature-active bacterial amylases derived from this strain is expected to rise significantly.

Bacillus coagulans:

Bacillus coagulans is recognized for its unique properties, particularly its ability to withstand acidic conditions while producing high levels of amylase. This strain is predominantly utilized in the food and beverage sector, specifically in fermented foods and beverages, where its enzymatic activity enhances texture and flavor. The versatility of Bacillus coagulans makes it an attractive option for manufacturers seeking to optimize production processes and improve product quality. Furthermore, the growing consumer trend towards probiotic and functional foods drives the demand for Bacillus coagulans-derived amylases, highlighting its significance in the evolving bacterial amylase market.

By Region

The Bacterial Amylase market exhibits significant growth across various regions, with North America leading the way due to its advanced technological landscape and robust end-use industries. The region is projected to account for approximately 30% of the global market share by 2035, driven by the increasing demand from the food and beverage sector, which emphasizes quality and sustainability. Moreover, the presence of key players and the ongoing research and development activities in enzyme technologies further bolster market growth in North America. The CAGR for the North American Bacterial Amylase market is expected to be around 8.2%, reflecting a positive outlook for the coming years.

In the Asia Pacific region, the Bacterial Amylase market is anticipated to witness substantial growth, with an expected market share of about 28% by 2035. The rapid expansion of the food and beverage and textile sectors in countries such as China and India significantly contributes to this growth. Additionally, the increasing focus on sustainable production practices and the adoption of enzyme technologies in various industries are anticipated to propel market demand in this region. The CAGR for the Asia Pacific market is projected to reach approximately 9%, driven by the growing industrialization and favorable government initiatives promoting biotechnological advancements.

Opportunities

The Bacterial Amylase market presents numerous opportunities for growth, particularly as industries continue to shift towards sustainable practices. The increasing demand for clean label products in the food and beverage sector drives manufacturers to seek efficient enzyme solutions that comply with consumer preferences for transparency and health. Furthermore, the rise of the biofuel industry opens new avenues for bacterial amylase applications, as the focus on renewable energy sources intensifies globally. Companies investing in research and development to innovate and enhance the efficiency of bacterial amylases will likely capture a significant share of the market in the coming years. Collaborations between enzyme manufacturers and end-user industries further present opportunities for tailored solutions that address specific processing challenges, reinforcing the role of bacterial amylases in various applications.

Additionally, the growing awareness of the benefits of enzyme-based solutions in improving productivity and reducing environmental impact positions the Bacterial Amylase market favorably for future expansion. As industries increasingly adopt enzyme technologies to optimize their processes, the demand for specialized bacterial amylases will rise. The trend towards personalized and functional foods also offers opportunities for manufacturers to develop innovative enzyme formulations that cater to specific consumer needs. Moreover, the expansion of the pharmaceutical sector, coupled with advancements in biotechnology, creates a promising landscape for the application of bacterial amylases, further enhancing their market potential in various sectors.

Threats

Despite the promising growth prospects, the Bacterial Amylase market faces several threats that could inhibit its expansion. One significant challenge is the presence of stringent regulatory requirements governing enzyme production and application, particularly in the food and pharmaceutical industries. Compliance with these regulations can impose additional costs and complexities for manufacturers, potentially hindering their operational efficiency and increasing the time required to bring products to market. Furthermore, the competition from alternative enzymatic solutions and synthetic substitutes poses a threat to the market, as industries may opt for cost-effective options that do not rely on bacterial sources. This competitive landscape necessitates continuous innovation and adaptation by manufacturers to maintain market relevance and capture consumer preference.

Additionally, fluctuations in raw material availability and pricing may impact the production cost of bacterial amylases. As industries strive for cost optimization, any volatility in sourcing raw materials could lead to increased operational costs, affecting the overall pricing strategy of manufacturers. The possibility of market saturation, particularly in mature regions, can also pose challenges to growth as competition intensifies. Companies need to differentiate their offerings and continually invest in research and development to address evolving market demands and maintain a competitive edge. The integration of technology and automation in production processes will be crucial for overcoming these threats and ensuring sustainable growth in the Bacterial Amylase market.

Competitor Outlook

• Novozymes A/S
• Genencor International Inc.
• Dupont de Nemours, Inc.
• AB Enzymes GmbH
• RIBI Immunochem Research Inc.
• Associated British Foods plc
• DSM Nutritional Products AG
• Enzymatic Deinking Technologies LLC
• Kraft Foods Group, Inc.
• Chr. Hansen Holding A/S
• Syngenta AG
• BASF SE
• BioCare Copenhagen A/S
• Carbohydrate Bioengineering LLC
• Biocatalysts Ltd.

The competitive landscape of the Bacterial Amylase market is characterized by the presence of both established players and emerging companies striving to capture market share through innovation and strategic collaborations. Key players like Novozymes A/S and Dupont de Nemours, Inc. have established themselves as leaders in enzyme solutions, leveraging their extensive research and development capabilities to introduce advanced formulations tailored to diverse applications. These companies focus on sustainability and efficiency, aligning with the growing demand for eco-friendly production methods. Additionally, the strategic partnerships between enzyme manufacturers and end-user industries enhance the development of customized solutions that meet specific processing requirements, fostering a collaborative approach to market growth.

Moreover, companies such as Genencor International Inc. and AB Enzymes GmbH are actively investing in expanding their product portfolios to cater to the evolving needs of various industries. The emphasis on biotechnology and enzyme engineering is driving innovation, leading to the development of more efficient bacterial amylases with enhanced functionalities. The focus on enhancing the stability, specificity, and activity of amylases is essential for maintaining competitive differentiation in the market. Furthermore, market players are increasingly exploring opportunities in emerging regions, where industrialization and growing consumer awareness are driving demand for enzyme-based solutions.

In summary, the competitive landscape of the Bacterial Amylase market is dynamic, with established companies continuously innovating while new entrants seek to establish their presence. Factors such as technological advancements, sustainability, and strategic collaborations are pivotal in shaping the future of this market. As industries evolve and consumer preferences shift towards cleaner and more efficient solutions, the overall competitive environment will continue to adapt, presenting both challenges and opportunities for market participants.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 BASF SE
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Syngenta AG
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Novozymes A/S
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 AB Enzymes GmbH
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Biocatalysts Ltd.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 BioCare Copenhagen A/S
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Chr. Hansen Holding A/S
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Dupont de Nemours, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Kraft Foods Group, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 DSM Nutritional Products AG
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Genencor International Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Associated British Foods plc
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 RIBI Immunochem Research Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Carbohydrate Bioengineering LLC
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Enzymatic Deinking Technologies LLC
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Bacterial Amylase Market, By Application
    • 6.1.1 Food & Beverage
    • 6.1.2 Textile
    • 6.1.3 Pharmaceutical
    • 6.1.4 Paper & Pulp
    • 6.1.5 Biofuel
  • 6.2 Bacterial Amylase Market, By Product Type
    • 6.2.1 Thermophilic Bacterial Amylase
    • 6.2.2 Mesophilic Bacterial Amylase
    • 6.2.3 Alkaliphilic Bacterial Amylase
    • 6.2.4 Acidophilic Bacterial Amylase
    • 6.2.5 Psychrophilic Bacterial Amylase
  • 6.3 Bacterial Amylase Market, By Ingredient Type
    • 6.3.1 Bacillus subtilis
    • 6.3.2 Bacillus licheniformis
    • 6.3.3 Bacillus amyloliquefaciens
    • 6.3.4 Bacillus stearothermophilus
    • 6.3.5 Bacillus coagulans
  • 6.4 Bacterial Amylase Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Indirect Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Bacterial Amylase Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Bacterial Amylase market is categorized based on

By Product Type

• Thermophilic Bacterial Amylase
• Mesophilic Bacterial Amylase
• Alkaliphilic Bacterial Amylase
• Acidophilic Bacterial Amylase
• Psychrophilic Bacterial Amylase

By Application

• Food & Beverage
• Textile
• Pharmaceutical
• Paper & Pulp
• Biofuel

By Distribution Channel

• Direct Sales
• Indirect Sales

By Ingredient Type

• Bacillus subtilis
• Bacillus licheniformis
• Bacillus amyloliquefaciens
• Bacillus stearothermophilus
• Bacillus coagulans

By Region

• Asia Pacific
• North America
• Latin America
• Europe
• Middle East & Africa

Key Players

• Novozymes A/S
• Genencor International Inc.
• Dupont de Nemours, Inc.
• AB Enzymes GmbH
• RIBI Immunochem Research Inc.
• Associated British Foods plc
• DSM Nutritional Products AG
• Enzymatic Deinking Technologies LLC
• Kraft Foods Group, Inc.
• Chr. Hansen Holding A/S
• Syngenta AG
• BASF SE
• BioCare Copenhagen A/S
• Carbohydrate Bioengineering LLC
• Biocatalysts Ltd.